falsefalse

Year in Review: Updates in Immunotherapy-Based Treatment Approaches for NSCLC - Episode 6

Advancements in Squamous NSCLC Treatment: Subgroup Analysis from EMPOWER-Lung Trials

Eduardo Santos, MD, FACP, FCCP, delves into advancements in the treatment of squamous NSCLC, emphasizing crucial insights from the EMPOWER-Lung01 and EMPOWER-Lung03 subgroup analysis.

Current Time 0:00
Duration 0:00
Loaded: 0%
Stream Type LIVE
Remaining Time 0:00
 
1x
  • Chapters
  • descriptions off, selected
  • captions off, selected
    EP. 1: Immunotherapy-Based Strategies for NSCLC in the Neoadjuvant/Perioperative Setting
    EP. 2: Advances in Neoadjuvant Immunotherapy for NSCLC: Conference Highlights 2023
    EP. 3: Updates in Adjuvant Immunotherapy for NSCLC: Conference Highlights 2023
    EP. 4: Immunotherapy-Based Treatment Strategies in Advanced NSCLC
    EP. 5: EMPOWER-Lung3: Evaluating Cemiplimab Plus Chemotherapy in Advanced NSCLC
    Now Viewing
    EP. 6: Advancements in Squamous NSCLC Treatment: Subgroup Analysis from EMPOWER-Lung Trials
    EP. 7: Advances in Dual Immunotherapy Approaches for NSCLC: Data Highlights 2023
    EP. 8: NSCLC 2023 Data Updates: Shaping the Future Treatment Landscape

    Related Content:

    Year in Review: Updates in Immunotherapy-Based Treatment Approaches for NSCLCVideo SeriesInsights Video SeriesInsightsLung Cancer
    Giants of Cancer Care® Announces the 13th Annual Class of Inductees
    Managing Brain Metastases in HER2+  Breast Cancer: Second-Line Treatment Decisions
    Balancing Cure and Toxicity: Tailoring AlloHSCT Intensity and Timing
    x